{"title": "Objetivo:", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2002-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Uso de vacuna Valergen DP en la rinitis al\u00e9rgica / Use of the Valergen DP vaccine in allergic rhinitis\n[Arch. m\u00e9d. Camaguey](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Arch. m\u00e9d. Camaguey); 15(4)20110700. gr\u00e1f\nArtigo em Espanhol | CUMED | ID: cum-47022\nBiblioteca respons\u00e1vel:\n[CU1.3](http://centros.bvsalud.org/?search=CU1.3&prefix=search&lang=pt)\nLocaliza\u00e7\u00e3o: CU1.3\nRESUMENLa\n[rinitis al\u00e9rgica]produce un importante deterioro de la [calidad de vida]. La [inmunoterapia sublingual], representa una v\u00eda natural para la inducci\u00f3n de la [tolerancia]en este desorden al\u00e9rgico.\nObjetivo:evaluar la\n[eficacia]y [seguridad]del extracto alerg\u00e9nico VALERGEN-DP del [\u00e1caro] [Dermatophagoides pteronyssinus]como [vacuna] [terap\u00e9utica]sublingual en [pacientes]con [rinitis al\u00e9rgica].\nM\u00e9todo:\n[ensayo cl\u00ednico], fase II, a doble ciegas, paralelo, aleatorizado, controlado con un grupo placebo. Las [vacunas]se suministraron por v\u00eda sublingual en un esquema de incremento de [dosis]. El [tratamiento]tuvo una duraci\u00f3n m\u00ednima de un a\u00f1o con evaluaciones frecuentes. Los 40 [pacientes]incluidos se asignaron a los dos grupos de forma pareja, 20 a cada uno, previo [consentimiento informado].\nResultados:se observ\u00f3 una disminuci\u00f3n promedio en la media de los\n[s\u00edntomas], as\u00ed como en el consumo de [medicamentos]en el grupo activo en relaci\u00f3n al placebo, dado por 156,3(p=0,000) y 43,5 (p=0,000) respectivamente. Los valores de la media de la reactividad cut\u00e1nea descendieron en el grupo activo no as\u00ed en el placebo en 2,6 %. Se reportaron solo cuatro eventos adversos, ninguno fatal, que representaron un 0,2 %.\nConclusiones:la\n[inmunoterapia sublingual]con Dermatophagoide pteronyssinus es eficaz y segura para el [tratamiento]de los [pacientes]con [rinitis al\u00e9rgica](AU)\nABSTRACT\n[Allergic rhinitis]produced a significant deterioration in the [quality of life]. [Sublingual immunotherapy]represents a natural way to induce tolerance in the allergic disorder.\nObjective:to assess the\n[efficacy]and [safety]of allergenic extract VALERGEN-DP from [mite] [Dermatophagoides pteronyssinus]as sublingual [therapeutic] [vaccine]in [patients]with [allergic rhinitis].\nMethod:a\n[clinical trial, phase II], double-blind, parallel, randomized, controlled with a placebo group was conducted. [Vaccines]were provided via sublingual in an increasing [dose] [schedule]. The [treatment]had a minimal duration of one year with frequent evaluations. The 40 [patients]included, two groups of 20 were assigned, previous [informed consent].\nResults:it was observed an average decrease in the mean of symptoms, as well as\n[drugs] [consumption]in the active group in relation to the placebo with 156,3 (p=0,000) and 43.5 (p = 0, 000) respectively. Values of the mean of [skin]reactivity declined in the active group not so in the placebo with 2.6 %. Only four adverse events were reported, none fatal, representing a 0.2 %.\nConclusions:\n[sublingual immunotherapy]with [Dermatophagoide]pteronyssinus is safe and effective for the [treatment]of [patients]with [allergic rhinitis](AU)\nTexto completo: Dispon\u00edvel Cole\u00e7\u00f5es: Bases de dados nacionais / Cuba Base de dados: CUMED Assunto principal: Administra\u00e7\u00e3o Sublingual / Rinite / Imunoterapia Ativa / Ensaios Cl\u00ednicos Fase II como Assunto / Dermatophagoides pteronyssinus Tipo de estudo: Ensaio cl\u00ednico controlado Aspecto: Prefer\u00eancia do paciente Limite: Humanos Idioma: Espanhol Revista: Arch. m\u00e9d. Camaguey Ano de publica\u00e7\u00e3o: 2011 Tipo de documento: Artigo Institui\u00e7\u00e3o/Pa\u00eds de afilia\u00e7\u00e3o: Hospital Pedi\u00e1trico Universitario Eduardo Agramonte Pi\u00f1a/Cuba / Hospital Universitario Manuel Ascunce Domenech/Cuba / Universidad de Ciencias M\u00e9dicas Carlos J Finlay/Cuba", "language": null, "image": null, "pagetype": null, "links": ["#main_container", "#pesquisa", "#footer", "#", "#", "#", "#", "https://politicas.bireme.org/accesibilidad/pt/", "http://bvsalud.org/", "javascript:change_language('pt')", "javascript:change_language('es')", "javascript:change_language('en')", "javascript:change_language('fr')", "https://pesquisa.bvsalud.org/portal/decs-locator/?lang=pt", "https://pesquisa.bvsalud.org/portal/advanced/?lang=pt", "http://bvsalud.org/evideasy/pt", "#", "http://bvsalud.org/", "https://pesquisa.bvsalud.org/portal/?lang=pt", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Sugra\u00f1es Montalv\u00e1n, Adianez\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Hern\u00e1ndez Veiga, Marelys\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Morales Men\u00e9ndez, Mar\u00eda\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Barreto Su\u00e1rez, Eduardo\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Sugra\u00f1es Montalv\u00e1n, Arianna\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=au:\"Ram\u00edrez Torres, Andr\u00e9s\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Arch. m\u00e9d. Camaguey", "http://centros.bvsalud.org/?search=CU1.3&prefix=search&lang=pt", "https://www.facebook.com/sharer.php?u=https://pesquisa.bvsalud.org/portal/resource/pt/cum-47022", "https://twitter.com/intent/tweet?text=Uso de vacuna Valergen DP en la rinitis al\u00e9rgica https://pesquisa.bvsalud.org/portal/resource/pt/cum-47022", "https://www.linkedin.com/shareArticle?mini=true&url=https://pesquisa.bvsalud.org/portal/resource/pt/cum-47022&title=Uso de vacuna Valergen DP en la rinitis al\u00e9rgica - Portal Regional da BVS", "https://api.whatsapp.com/send?text=Uso de vacuna Valergen DP en la rinitis al\u00e9rgica - Portal Regional da BVS - https://pesquisa.bvsalud.org/portal/resource/pt/cum-47022", "#mark_ab_es", "#mark_ab_en", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Humanos\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Imunoterapia Ativa\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Dermatophagoides pteronyssinus\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Rinite\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Ensaios Cl\u00ednicos Fase II como Assunto\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=mh:\"Administra\u00e7\u00e3o Sublingual\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"INMUNOTERAPIA ACTIVA\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"DERMATOPHAGOIDES PTERONYSSINUS\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"RINITIS\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"ENSAYO CL\u00cdNICO FASE II\"", "https://pesquisa.bvsalud.org/portal/?lang=pt&q=kw:\"ADMINISTRACI\u00d3N SUBLINGUAL\"", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552011000400005&lng=es&nrm=iso&tlng=es", "javascript:;", "javascript:window.print()", "javascript:export_xml_record('cum-47022');", "https://www.google.com/search?q=\"Uso de vacuna Valergen DP en la rinitis al\u00e9rgica\"", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552011000400005&lng=es&nrm=iso&tlng=es", "javascript:;", "javascript:window.print()", "javascript:export_xml_record('cum-47022');", "https://www.google.com/search?q=\"Uso de vacuna Valergen DP en la rinitis al\u00e9rgica\"", "https://bvsalud.org/contate-nos/", "http://politicas.bireme.org/terminos/pt/", "http://politicas.bireme.org/privacidad/pt/", "javascript:change_output('rss');", "javascript:;", "javascript:print_page();", "javascript:print_page(true);"]}